SEC Form 4 · accession 0001773751-26-000210
Hims & Hers Health, Inc. · HIMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Oluyemi Okupe
Officer — Chief Financial Officer
Period of report
Jun 18, 2026
Accepted (ET)
Aug 18, 2026 · 5:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001773751
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Jun 18, 2026 | S | 55,383 | $35.09 | D | 228,938 | D | |
| Class A Common StockF3 | Aug 14, 2026 | M | 71,616 | — | A | 300,554 | D | |
| Class A Common StockF4 | Aug 14, 2026 | F | 36,437 | $28.15 | D | 264,117 | D | |
| Class A Common Stock | Aug 17, 2026 | M | 9,388 | $5.01 | A | 273,505 | D | |
| Class A Common StockF5 | Aug 17, 2026 | S | 9,388 | $27.8869 | D | 264,117 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F6 | — | Aug 14, 2026 | M | 18,335 | D | — | — | Class A Common Stock | 18,335 | 36,669 | D |
| Restricted Stock UnitF3,F7 | — | Aug 14, 2026 | M | 22,988 | D | — | — | Class A Common Stock | 22,988 | 137,929 | D |
| Restricted Stock UnitF3,F8 | — | Aug 14, 2026 | M | 11,482 | D | — | — | Class A Common Stock | 11,482 | 114,825 | D |
| Restricted Stock UnitF3,F9 | — | Aug 14, 2026 | M | 18,811 | D | — | — | Class A Common Stock | 18,811 | 263,356 | D |
| Stock Option (right to buy)F10 | $5.01 | Aug 17, 2026 | M | 9,388 | D | — | Feb 23, 2032 | Class A Common Stock | 9,388 | 85,810 | D |
Explanation of responses
- F1The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
- F10This stock option award is fully vested.
- F2Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.95 - $35.36. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
- F4The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
- F5Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.59 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.
- F7The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.
- F8The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.
- F9The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.